2406-05-5

Upstream product

• 83-34-1 3-Methylindole 

Downstream Products

• 1390618-87-7 C₂₄H₂₂N₂O₃ 
• 1390618-88-8 4-(3-methyl-2-oxo-1-phenyl-2,3-dihydro-1H-indol-3-ylamino)-benzoic acid methyl ester 
• 1390618-50-4 N-hydroxy-4-(3-methyl-2-oxo-1-phenyl-2,3-dihydro-1H-indol-3-ylamino)-benzamide 
• 1390618-46-8 4-(1-Benzyl-3-methyl-2-oxo-2,3-dihydro-1H-indol-3-ylamino)-N-hydroxy-benzamide 
• 1390618-68-4 4-(3-methyl-2-oxo-2,3-dihydro-1H-indol-3-ylamino)-benzoic methyl ester 
• 1396629-44-9 3-methyl-3-((4-(trifluoromethyl)phenyl)amino)indolin-2-one 

Relevant academic research and scientific papers

Enantioselective [4 + 2] Cycloaddition/Cyclization Cascade Reaction and Total Synthesis of cis-Bis(cyclotryptamine) Alkaloids

The asymmetric catalytic synthesis of 3-cyclotryptamine substituted oxindoles through formal [4 + 2] cycloaddition/cyclization cascade is described. A wide range of cyclotryptamine derivatives were obtained in enantioenriched form under mild reaction conditions and were found to have potential anticancer activity. The strategy enables ready assembly of cyclotryptamine subunits at the C3a-C3a′ positions with two quaternary stereogenic centers in cis-selectivity, leading to the concise synthesis of optically active cis-bis(hexahydropyrroloindole) and others of the cyclotryptamine alkaloid family.

NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES FOR THE TREATMENT OF CANCER

The present invention provides compounds of formula or pharmaceutically acceptable salts, esters or stereoisomers thereof, wherein R1 to R4, A and Y have the meanings given herein, as well as methods for making those compounds and their use as medicament, in particular as medicament for the treatment of cancer.

NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER

The present invention provides HDAC inhibitors of formula (I), or pharmaceutically acceptable salts, esters or stereoisomers thereof, wherein R1 to R4, A and Y have the meanings given herein, as well as methods for making those compounds and their use as medicament, in particular as medicament for the treatment of cancer

Total Synthesis of (±)-Perophoramidine

The first total synthesis of racemic perophoramidine is described. The key step features the highly stereoselective introduction of the vicinial quaternary centers via base-promoted carbon-carbon bond formation between a 3-alkylindole and a 3-bromo-3-alkylindolin-2-one. This transformation presumably proceeds through a conjugate addition or Diels-Alder cycloaddition of the 3-alkylindole with a 3-alkylindol-2-one intermediate. Copyright